Responsiveness to estradiol-17β and to phytoestrogens in primary human osteoblasts is modulated differentially by high glucose concentration

Journal of Steroid Biochemistry and Molecular Biology

Volumn 99, Issue 2-3, 2006, Pages 139-146

  Somjen, Dalia ^a   Katzburg, Sara ^a   Kohen, Fortune ^b   Gayer, Batya ^b   Sharon, Orly ^a   Hendel, David ^c   Kaye, Alvin M ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Creatine kinase; Estrogen receptors and ; Human primary osteoblasts; Hyperglycemia; Phytoestrogens; Sex and age specificity

Indexed keywords

ANDROSTANOLONE; BIOCHANIN A; CREATINE KINASE; DAIDZEIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENISTEIN; GLUCOSE; MESSENGER RNA; PHYTOESTROGEN; QUERCETIN; CREATINE KINASE BB; DRUG DERIVATIVE;

ADULT; ARTICLE; BONE CELL; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; FEMALE; GROUPS BY AGE; HUMAN; HUMAN CELL; MALE; MEMBRANE BINDING; OSTEOBLAST; PROTEIN EXPRESSION; AGE; AGED; BINDING COMPETITION; CELL CULTURE; CELL MEMBRANE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION; GENETICS; METABOLISM; MIDDLE AGED; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BINDING, COMPETITIVE; CELL MEMBRANE; CELLS, CULTURED; CREATINE KINASE, BB FORM; DIHYDROTESTOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION; GENISTEIN; GLUCOSE; HUMANS; MALE; MIDDLE AGED; OSTEOBLASTS; PHYTOESTROGENS; QUERCETIN; SEX FACTORS;

EID: 33646175473     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2005.12.008     Document Type: Article

References (31)

1. Somjen D., Weisman Y., Harell A., Berger E., and Kaye A.M. Direct and sex specific stimulation by sex steroids of creatine kinase activity and DNA synthesis in rat bone. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 3361-3363
2. Somjen D., Weisman Y., Mor Z., Harell A., and Kaye A.M. Regulation of proliferation of rat cartilage and bone by sex steroid hormones. J. Steroid Biochem. Mol. Biol. 40 (1991) 717-723
3. Kaye A.M., Weisman Y., Harell A., and Somjen D. Hormonal stimulation of bone cell proliferation. J. Steroid Biochem. Mol. Biol. 37 (1990) 431-435
4. Reiss N., and Kaye A.M. Identification of the major component of the estrogen induced protein of rat uterus as the BB isozyme of creatine kinase. J. Biol. Chem. 256 (1981) 5741-5749
5. Malnick S.D.H., Shaer A., Soreq H., and Kaye A.M. Estrogen induced creatine kinase in the reproductive system of the immature female rat. Endocrinology 19 (1983) 1907-1909
6. Fournier B., Haring S., Kaye A.M., and Somjen D. Stimulation of creatine kinase specific activity in human osteoblast and endometrial cells by estrogens and anti-estrogens and its modulation by calciotropic hormones. J. Endocrinol. 150 (1996) 275-285
7. Gray T.K., Flynn T.C., Gray K.M., and Nabell L.M. 17β estradiol acts directly on the clonal osteoblast cell line UMR 106. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 854-857
8. Eriksen E.F., Colard D.S., Berg N.J., Graham M.L., Mann K.G., Spelsberg T.C., and Riggs B.L. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241 (1988) 84-86
9. Komm B.S., Terpening C.M., Benz D.J., Graeme K.A., Kox M., Greene A.G.L., Gallegos A., O'Mally B.W., and Haussler M.R. Estrogen binding, receptor mRNA, and biological response in osteoblast-like osteosarcoma cells. Science 241 (1988) 81-84
10. Cosman F., and Lindsay R. Selective estrogen receptor modulators: clinical spectrum. Endocr. Rev. 20 (1999) 418-434
11. Manolagas S.C., Kousteni S., and Jilka R.L. Sex steroids and bone. Recent Progr. Horm. Res. 57 (2002) 385-409
12. Enmark E., and Gustafsson J.A. Oestrogen receptors-an overview. J. Intern. Med. 246 (1999) 133-138
13. Miksicek R.J. Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J. Steroid Biochem. Mol. Biol. 49 (1994) 153-160
14. Delmas P.D. Treatment of postmenopausal osteoporosis. Lancet 359 (2000) 2018-2026
15. Gooren L.J., and Toorians A.W. Significance of oestrogens in male (patho) physiology. Ann. Endocrinol. 64 (2003) 126-135
16. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. J. Am. Med. Assoc. 288 (2002) 321-333
17. Katzburg S., Lieberherr M., Ornoy A., Klein B.Y., Hendel D., and Somjen D. Isolation and hormonal responsiveness of primary cultures of human bone-derived cells: gender and age differences. Bone 25 (1999) 667-673
18. Katzburg S., Ornoy A., Hendel D., Lieberherr M., Kaye A.M., and Somjen D. Age and gender specific stimulation of creatine kinase specific activity by gonadal steroids in human bone-derived cells in culture. J. Endocrin. Invest. 24 (2001) 166-172
19. Brzezinski A., and Debi A. Phytoestrogens: the "natural" selective estrogen receptor modulators?. J. Obstet. Gynecol. Reprod. Biol. 85 (1999) 47-51
20. Tham D.M., Gardner C.D., and Haskell W.L. Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J. Clin. Endocrinol. Metab. 83 (1998) 2223-2235
21. Setchell K.D., and Lydeking-Olsen E. Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am. J. Clin. Nutr. 78 (2003) 593S-609S
22. Morabito N., Crisafulli A., Vergara C., Gaudio A., Lasco A., Frisina N., D'Anna R., Corrado F., Pizzoleo M.A., Cincotta M., Altavilla D., lentile R., and Squadrito F. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J. Bone Miner. Res. 17 (2002) 1904-1912
23. Ishimi Y., Arai N., Wang X., Wu J., Umegaki K., Miyaura C., Takeda A., and Ikegami S. Difference in effective dosage of genistein on bone and uterus in ovariectomized mice. Biochem. Biophys. Res. Commun. 274 (2000) 697-701
24. He H., Liu R., Desta T., Leon C., Gerstenfeld L.C., and Graves D.T. Diabetes causes decreased osteoclastogenesis, reduced bone formation and enhanced apoptosis of osteoblastic cells in bacteria stimulated bone loss. Endocrinology 145 (2004) 447-452
25. Goodman W., and Hori M. Diminished bone formation in experimental diabetes. Relationship to osteroid maturation and mineralization. Diabetes 33 (1984) 825-831
26. Somjen D., Zaltsman Y., Gayer B., Kulik T., Knoll E., Stern N., Lu L.J.W., Toldo L., and Kohen F. 6-Carboxymethyl genistein: a novel selective oestrogen receptor modulator (SERM) with unique differential effects on the vasculature, bone and uterus. J. Endocrinol. 173 (2002) 415-427
27. Somjen D., Kohen F., Lieberherr M., Gayer B., Schejter E., Katzburg S., Limor R., Sharon O., Knoll E., Posner G.H., Kaye A.M., and Stern N. Membranal effects of phytoestrogens and carboxy-derivatives of phytoestrogens on human vascular and bone cells: new insights based on studies with carboxy-biochanin A. J. Steroid Biochem. Mol. Biol. 93 (2005) 293-303
28. Somjen D., Kohen F., Gayer B., Sharon O., Limor R., Kulik T., Knoll E., and Stern N. Role of putative membrane receptors in estradiol's effects on human vascular cell growth. Am. J. Hyperten. 17 (2004) 462-469
29. Somjen D., Paller C.J., Gayer B., Kohen F., Knoll E., and Stern N. High glucose blocks estradiol's effects on human vascular cell growth: differential interaction with estradiol and raloxifene. J. Steroid Biochem. Mol. Biol. 88 (2004) 101-110
30. Effects of menopause and estrogen replacement therapy or hormone replacement therapy in women with diabetes mellitus: consensus opinion of The North American Menopause Society, Menopause 7 (2000) 87-95.
31. Liu E.Y., Wactawaski-Wende J., Donhaue R.P., Dmochowski J., Hovey K.M., and Quattrin T. Does low bone mineral density start in post-teenage years in women with type 1 diabetes?. Diabetes Care 26 (2003) 2365-2369